Some of the TRPM7 modulators have been tested in cancer cells, such as a clinically used anesthetic (midazolam), naturally occurring compounds (ginsenoside Rg3, ginsenoside Rd, waixenicin A, carvacrol, and xyloketal B), and the synthetic compound NS8593. This evidence concerns the gene TRPM7 and cancer.